Patients with schizophrenia who take antipsychotic medications appear to lose a small but measurable amount of brain tissue over time, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Schizophrenia affects 1 percent of the worldwide population and remains a leading cause of chronic disability among […]
Depression is expected to constitute the second largest source of global burden of disease after heart disease by the year 2020. The consequences for society and individuals are lowered quality of life, social isolation, decreased intellectual capacity as well as an inability to carry out activities of daily living. Additional consequences are significantly affected health […]
The Tufts Clinical and Translational Science Institute (CTSI) today issued a landmark report from a multi-state study on psychotropic medication oversight in foster care. Led by Laurel K. Leslie, MD, MPH at Tufts CTSI, Christopher Bellonci, MD at Tufts Medical Center and Justeen Hyde, PhD at Cambridge Health Alliance, the study examined state policies and […]
Recent Comments